Author: AIM Network - Bewertung: 199x - Views:6601
Isomorphic Labs recently secured $2.1 billion in Series B funding, highlighting the growing venture capital and investment in cutting-edge biotechnology. This significant capital injection will accelerate their pioneering work in AI-driven drug discovery and development, with the first human trials of AI-designed medicines anticipated by 2026. Their focus remains on leveraging artificial intelligence to advance from protein mapping to molecular design, promising a new era for AI in healthcare.
#Google #VentureCapital #Investment #AIinHealthCare #FrontPage #AIMNetwork
------------------------------------------------------------------------------------------
👋 ABOUT AIM NETWORK
AIM Network is India's leading voice on the intersection of AI, Technology, and Business. We bring you sharp analysis, breaking news, and original perspectives on everything from Generative AI breakthroughs to geopolitical market shifts.
🔔 Subscribe for daily insights: https://www.youtube.com/@aimmediahouse?sub_confirmation=1
📺 WATCH OUR POPULAR SERIES:
- Front Page (Daily Tech News): https://www.youtube.com/playlist?list=PL9Kc1zSa46OxR8h0ZgAfEENta0vaxfWrs
- Tech Talks (Podcast): https://www.youtube.com/playlist?list=PL9Kc1zSa46OyXflFLWtmF5MN3jvdxDFE3
-Simulated Reality (Podcast) - https://www.youtube.com/playlist?list=PL9Kc1zSa46OwqKv91j8W6vZ-V5DucIU4Y
📰 STAY UPDATED:
Website: https://analyticsindiamag.com/
LinkedIn: https://in.linkedin.com/company/analytics-india-magazine
Twitter/X: https://x.com/Analyticsindiam
Instagram: https://www.instagram.com/aim.media.house/
------------------------------------------------------------------------------------------
SOCIAL SHARE CARD GENERATOR